Blood advances

Keyphrases

Publications

2023

Ian W Smith, Ernest T Parker, Pete Lollar
pH-Dependent Conformation of Multimeric von Willebrand Factor. Blood advances (2023)
Claire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, Katharine Patrick, Naeem Akram Butt, Oana Mirci-Danicar, Olya O'Connor, Caroline Louise Furness, Akshay Deshpande, Sarah Lawson, Valerie Broderick, Pamela Evans, Brenda Es Gibson, Wing Roberts, Salah Ali, Sevasti Galani, Amy A Kirkwood, Jelena Jovanovic, Richard James Dillon, Paul Virgo, Beki James, Kanchan Rao, Persis Jal Amrolia, Robert Wynn
T-replete cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy. Blood advances (2023)
Cansu Koyunlar, Emanuele Gioacchino, Disha Vadgama, Hans W J de Looper, Joke Zink, Mariette Ter Borg, Remco Hoogenboezem, Marije Havermans, Mathijs Arnoud Sanders, Eric Bindels, Elaine A Dzierzak, Ivo P Touw, Emma de Pater
Gata2-regulated Gfi1b expression controls endothelial programming during endothelial-to-hematopoietic transition. Blood advances (2023)
Pablo Toledano Sanz, Paula Reventún, Maria Viskadourou, William O Osburn, Nunzio Alcharani, Charles Lowenstein, Marios Arvanitis
The transcriptional landscape of human liver endothelial cells. Blood advances (2023)
Ariel Kleman, Arun K Singavi, Lauren Pommert, Angela Joy Mathison, Parameswaran N Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer Mary Knight, Mithun Vinod Shah, Carolina D Schinke, Robert Thomas Burns, George Francis Steinhardt, Sridhar Rao, Karen-Sue Barker Carlson
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. Blood advances (2023)
Yagahira E Castro-Sesquen, Santosh L Saraf, Victor R Gordeuk, Sergei Nekhai, Marina Jerebtsova
Use of Multiple Urinary Biomarkers for the Early Detection of Chronic Kidney Disease in Sickle Cell Anemia. Blood advances (2023)
Rohtesh S Mehta, David C Marin, Amin Alousi, Christopher G Kanakry, Richard E Champlin, Katayoun Rezvani, Elizabeth J Shpall, Kristin M Page, Shahinaz M Gadalla, Daniel J Weisdorf, Partow Kebriaei
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. Blood advances (2023)

volume 7, number 10, 2023

James L LaBelle
Small but mighty: T-replete cords for myeloid disease. Blood advances 7 (10) (2023)
James L LaBelle
Small but mighty: T-replete cords for myeloid disease. Blood advances 7 (10) (2023)

volume 7, number 11, 2023

Jeffery J Auletta
On a collision course: SARS-CoV-2 variants and CAR T cells. Blood advances 7 (11) (2023)

volume 7, number 12, 2023

Simone Cenci
A wholesale approach to disarm multiple myeloma. Blood advances 7 (12) (2023)
Simone Cenci
A wholesale approach to disarm multiple myeloma. Blood advances 7 (12) (2023)
Oren Pasvolsky, Qaiser Bashir
Autologous transplant and second malignancies in MM. Blood advances 7 (12) (2023)

volume 7, number 13, 2023

Olubusola Oluwole, Enrico M Novelli
It's high time to turn the spotlight on HbSC disease. Blood advances 7 (13) (2023)

volume 7, number 14, 2023

David Qualls, Caron A Jacobson
Comorbidities in DLBCL: too "Severe4" CAR-T therapy? Blood advances 7 (14) (2023)

volume 7, number 15, 2023

Eric Boilard, Kellie R Machlus
Peripheral megakaryocytes sound the alarm in COVID-19. Blood advances 7 (15) (2023)
Jonathan A Webster, Leo Luznik
This CAR won't start: predicting nonresponse in ALL. Blood advances 7 (15) (2023)

volume 7, number 16, 2023

Sergiu Pasca, Matthew Z Guo, Shiyu Wang, Kristin Stokvis, Audra Shedeck, Aparna Pallavajjala, Cynthia Shams, Roshni Pallavajjala, Amy E DeZern, Ravi Varadhan, Christopher D Gocke, Richard J Jones, Lukasz P Gondek
Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes. Blood advances 7 (16) (2023)
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K Buadi, Joselle M Cook, David Dingli, Angela Dispenzieri, Amie L Fonder, Morie A Gertz, Wilson Gonsalves, Suzanne R Hayman, Miriam A Hobbs, Yi L Hwa, Taxiarchis V Kourelis, Martha Q Lacy, Nelson R Leung, Yi Lin, Rahma M Warsame, Robert A Kyle, S Vincent Rajkumar, Shaji K Kumar
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy. Blood advances 7 (16) (2023)
Anthony Quagliano, Anilkumar Gopalakrishnapillai, Sonali P Barwe
Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies. Blood advances 7 (16) (2023)
Holly M Wobma, Malika Kapadia, Haesook T Kim, Francesca Alvarez-Calderon, Susanne H C Baumeister, Christine Duncan, Suzanne J Forrest, Lev Gorfinkel, Jennifer Huang, Leslie E Lehmann, Hojun Li, Marc Andre Schwartz, John Koreth, Jerome Ritz, Leslie S Kean, Jennifer S Whangbo
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. Blood advances 7 (16) (2023)
Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoffrey L Uy, Wendy Stock, Bayard L Powell, Deedra Nicolet, Erin K Hertlein, Krzysztof Mrózek, James S Blachly, Ann-Kathrin Eisfeld, Sharyn D Baker, John C Byrd
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood advances 7 (16) (2023)
John E Levine
More evidence for low-dose IL-2 for chronic GVHD in children. Blood advances 7 (16) (2023)
Henny Heisler Billett, Morayma Reyes Gil
Diagnosing TMAs by automated red cell morphology analyses. Blood advances 7 (16) (2023)

volume 7, number 17, 2023

Kevin Quann, Faruk Sacirbegovic, Warren D Shlomchik
Natalizumab for GVHD: too little or too late? Blood advances 7 (17) (2023)

volume 7, number 18, 2023

Alvin H Schmaier
Histidine-rich glycoprotein: antithrombosis without bleeding. Blood advances 7 (18) (2023)
Ramya Ramaswami, Thomas S Uldrick
Remission after rituximab for HHV8+ MCD: what next? Blood advances 7 (18) (2023)
Matthew R Schuelke, Hamid Bassiri, Edward M Behrens, Scott W Canna, Colleen Croy, Amanda DiNofia, Kandace Gollomp, Stephan Grupp, Michele P Lambert, Arathi Lambrix, Shannon L Maude, Regina M Myers, Haley M Newman, Whitney Petrosa, Alix E Seif, Kathleen E Sullivan, David Trent Teachey, Caroline Diorio
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood advances 7 (18) (2023)
Julie-An Talano, Larisa Broglie
Haplo ever after: haplo PTCy for children. Blood advances 7 (18) (2023)

volume 7, number 19, 2023

Natasha M Archer
Further evidence supporting the global use of hydroxyurea. Blood advances 7 (19) (2023)
Mitchell E Horwitz
Blood stem cell grafts: frozen is fine, but fresh is best. Blood advances 7 (19) (2023)
Jonathan U Peled, Kate A Markey
The sweet taste of liberalizing dietary restrictions in HCT. Blood advances 7 (19) (2023)

volume 7, number 20, 2023

Gloria F Gerber, Robert A Brodsky
ADP: the missing link between thrombosis and hemolysis. Blood advances 7 (20) (2023)

volume 7, number 21, 2023

Mark R Dowling, Cameron J Turtle
ICANS prophylaxis: potentially transformative but elusive. Blood advances 7 (21) (2023)

volume 7, number 22, 2023

Norbert Schmitz, Imke E Karsten
Ibrutinib in the treatment of relapsed FL and MZL? Blood advances 7 (22) (2023)
Victoria Y Ling, Steven W Lane
Clearing the way for new therapies in clonal hematopoiesis. Blood advances 7 (22) (2023)

volume 7, number 4, 2023

Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Gladstone A A Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Augusto Vercillo Luisi, Veronique Minard Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin Norris, Mitchell Cairo
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Gladstone A A Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Augusto Vercillo Luisi, Veronique Minard Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin Norris, Mitchell Cairo
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood advances 7 (4) (2023)
Gladstone A A Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Augusto Vercillo Luisi, Veronique Minard Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin Norris, Mitchell Cairo
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood advances 7 (4) (2023)

volume 7, number 5, 2023

Toshiki Terao, Ken-Ichi Matsuoka, Hiroko Ueda, Akifumi Matsumura, Chisato Matsubara, Kaho Kondo, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Yoshinobu Maeda, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML. Blood advances 7 (5) (2023)
Toshiki Terao, Ken-Ichi Matsuoka, Hiroko Ueda, Akifumi Matsumura, Chisato Matsubara, Kaho Kondo, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Yoshinobu Maeda, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML. Blood advances 7 (5) (2023)
Toshiki Terao, Ken-Ichi Matsuoka, Hiroko Ueda, Akifumi Matsumura, Chisato Matsubara, Kaho Kondo, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Yoshinobu Maeda, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML. Blood advances 7 (5) (2023)

volume 7, number 6, 2023

Laura Hertz, Daniel A D Flormann, Lutz Birnbaumer, Christian Wagner, Matthias W Laschke, Lars Kaestner
Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood advances 7 (6) (2023)
Laura Hertz, Daniel A D Flormann, Lutz Birnbaumer, Christian Wagner, Matthias W Laschke, Lars Kaestner
Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood advances 7 (6) (2023)

volume 7, number 9, 2023

Jennifer Davila, Joseph R Stanek, Sarah H O'Brien
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients. Blood advances 7 (9) (2023)
Jennifer Davila, Joseph R Stanek, Sarah H O'Brien
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients. Blood advances 7 (9) (2023)
Jennifer Davila, Joseph R Stanek, Sarah H O'Brien
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients. Blood advances 7 (9) (2023)